CXCL12 and endometrial cancer: The mutual interaction between TGF-β1 and CXCL12 led to the increased tumorigenesis, invasion, migration, and EMT of endometrial cancer cells in vitro and in vivo, which can be reversed by neutralizing antibodies of either CXCL12 or CXCR4 [103].